Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS

Clinical trial NCT00573443 · COMPLETED

Trial details

NCT number: NCT00573443
Sponsor: Avanir Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pseudobulbar Affect (PBA)

Start date: 2007-12-01
Primary completion: 2009-06-01
Enrollment: 326

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.